KUVAN

Serial Number 78869434
Registration 3410811
800

Registration Progress

Application Filed
Apr 25, 2006
Under Examination
Feb 20, 2007
Approved for Publication
Nov 8, 2006
Published for Opposition
Nov 28, 2006
Registered
Apr 8, 2008

Trademark Image

KUVAN

Basic Information

Serial Number
78869434
Registration Number
3410811
Filing Date
April 25, 2006
Registration Date
April 8, 2008
Published for Opposition
November 28, 2006
Renewal Date
April 8, 2018
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Oct 10, 2017
Registration
Registered
Classes
005

Rights Holder

Biomarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

Biomarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

Biomarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

Biomarin Pharmaceutical Inc.

Original Registrant
03
Novato, CA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

Next Deadline
999 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-04-08)
Due Date
April 08, 2028
Grace Period Ends
October 08, 2028

Application History

34 events
Date Code Type Description
Oct 10, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 10, 2017 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 10, 2017 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 10, 2017 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 7, 2017 E89R I TEAS SECTION 8 & 9 RECEIVED
Apr 8, 2017 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 18, 2014 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 18, 2014 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 17, 2014 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 3, 2014 E815 I TEAS SECTION 8 & 15 RECEIVED
Apr 3, 2014 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Apr 8, 2008 R.PR A REGISTERED-PRINCIPAL REGISTER
Mar 5, 2008 ALIE A ASSIGNED TO LIE
Mar 5, 2008 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
Feb 9, 2008 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 4, 2008 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jan 9, 2008 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 9, 2008 IUAF S USE AMENDMENT FILED
Jul 9, 2007 EEXT I TEAS EXTENSION RECEIVED
Jul 9, 2007 EXT1 S EXTENSION 1 FILED
Jul 9, 2007 EX1G S EXTENSION 1 GRANTED
Feb 20, 2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 28, 2006 PUBO A PUBLISHED FOR OPPOSITION
Nov 8, 2006 NPUB O NOTICE OF PUBLICATION
Oct 5, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 28, 2006 ALIE A ASSIGNED TO LIE
Sep 19, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2006 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2006 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2006 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2006 DOCK D ASSIGNED TO EXAMINER
Aug 10, 2006 CPRA R PRIORITY ACTION WRITTEN
Aug 10, 2006 GPRA F PRIORITY ACTION E-MAILED
May 1, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceuticals comprising tetrahydrobiopterin (BH4) and related compounds for treatment of phenylketonuria
First Use Anywhere: Dec 14, 2007
First Use in Commerce: Dec 14, 2007

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...